Article Data

  • Views 84
  • Dowloads 12

Original Research

Open Access

Electrocardiographic findings and risk factors for mortality in octogenarians with pulmonary thromboembolism

  • Tufan Akın Giray1
  • Ali Sağlık1,*,
  • Ayşegül Akçebe1
  • Tarık Ocak1

1Department of Emergency Medicine, Medical Faculty, Istanbul Istinye University, 34010 Istanbul, Turkey

DOI: 10.22514/sv.2025.172 Vol.21,Issue 11,November 2025 pp.64-69

Submitted: 28 December 2024 Accepted: 21 March 2025

Published: 08 November 2025

*Corresponding Author(s): Ali Sağlık E-mail: alisaglik83@hotmail.com

Abstract

Background: This study aimed to investigate the electrocardiographic risk factors associated with mortality in elderly patients diagnosed with pulmonary thromboembolism (PTE). Methods: This multicenter, retrospective study analyzed electrocardiograms (ECGs) of patients aged 80 years and older at the time of their initial PTE diagnosis. Additionally, patient outcomes were assessed to determine whether death occurred due to PTE or related complications within a follow-up period of 180 days. The relationship between electrocardiographic findings and 30-day and 180-day mortality was examined. Results: A total of 241 patients were included, with a mean age of 83.5 ± 2.6 years; 143 (59.3%) were female. The most common electrocardiographic abnormality was sinus tachycardia, observed in 73.4% of patients. Mortality was recorded in 64 patients (26.5%) within 30 days and 88 patients (36.5%) within 180 days. The strongest predictor of 30-day mortality was ST segment (ST) depression in leads V4–6 (odds ratio (OR) 14.5; 95% confidence interval (CI) 5.1–41.0), while the most significant predictor of 180-day mortality was ST elevation in leads V1, augmented Vector Right (aVR) lead, or III (OR 15.8; 95% CI: 6.6–37.7). Conclusions: Pulmonary thromboembolism in octogenarians is associated with high mortality. Electrocardiographic evaluation at the time of diagnosis is crucial, as specific ECG abnormalities may serve as important prognostic indicators for 30-day and 180-day mortality.


Keywords

Electrocardiography; Pulmonary thromboembolism; Geriatrics; Mortality; Octogenarians


Cite and Share

Tufan Akın Giray,Ali Sağlık,Ayşegül Akçebe,Tarık Ocak. Electrocardiographic findings and risk factors for mortality in octogenarians with pulmonary thromboembolism. Signa Vitae. 2025. 21(11);64-69.

References

[1] Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). European Respiratory Journal. 2019; 54: 1901647.

[2] Robert-Ebadi H, Righini M. Diagnosis and management of pulmonary embolism in the elderly. European Journal of Internal Medicine. 2014; 25: 343–349.

[3] Hepburn-Brown M, Darvall J, Hammerschlag G. Acute pulmonary embolism: a concise review of diagnosis and management. Internal Medicine Journal. 2019; 49: 15–27.

[4] Bolt L, Lauber S, Limacher A, Samim D, Löwe A, Tritschler T, et al. Prognostic value of electrocardiography in elderly patients with acute pulmonary embolism. The American Journal of Medicine. 2019; 132: e835–e843.

[5] Zuin M, Nohria A, Henkin S, Krishnathasan D, Sato A, Piazza G. Pulmonary embolism-related mortality in patients with cancer. JAMA Network. 2025; 8: e2460315.

[6] Hendriks PM, Kauling RM, Geenen LW, Eindhoven JA, Roos-Hesselink JW, Boomars KA, et al. Role of the electrocardiogram in the risk stratification of pulmonary hypertension. Heart. 2023; 109: 208–215.

[7] Geibel A, Zehender M, Kasper W, Olschewski M, Klima C, Konstantinides SV. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. European Respiratory Journal. 2005; 25: 843–848.

[8] Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M. QR in V1—an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. European Heart Journal. 2003; 24: 1113–1119.

[9] Stein PD, Matta F, Sabra MJ, Treadaway B, Vijapura C, Warren R, et al. Relation of electrocardiographic changes in pulmonary embolism to right ventricular enlargement. The American Journal of Cardiology. 2013; 112: 1958–1961.

[10] Kukla P, McIntyre WF, Fijorek K, Mirek-Bryniarska E, Bryniarski L, Krupa E, et al. Electrocardiographic abnormalities in patients with acute pulmonary embolism complicated by cardiogenic shock. The American Journal of Emergency Medicine. 2014; 32: 507–510.

[11] Toosi MS, Merlino JD, Leeper KV. Electrocardiographic score and short-term outcomes of acute pulmonary embolism. The American Journal of Cardiology. 2007; 100: 1172–1176.

[12] Borkowski P, Singh N, Borkowska N, Mangeshkar S, Nazarenko N. Integrating cardiac biomarkers and electrocardiogram in pulmonary embolism prognosis. Cureus. 2024; 16: e53505.

[13] Camaro C, Aarts GWA, Adang EMM, van Hout R, Brok G, Hoare A, et al. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial. European Heart Journal. 2023; 44: 1705–1714.

[14] Liu D, Duan B, Zhao M, Wu L, Cao Y, Liu N, et al. ST-segment alterations in the electrocardiogram of acute pulmonary thromboembolism: a rabbit model. Physiological Research. 2024; 73: 543–552.

[15] Ma J, Li C, Zhai Z, Zhen Y, Wang D, Liu M, et al. Distribution of thrombus predicts severe reperfusion pulmonary edema after pulmonary endarterectomy. Asian Journal of Surgery. 2023; 46: 3766–3772.

[16] B Baranga L, Khanuja S, Scott JA, Provancha I, Gosselin M, Walsh J, et al. In situ pulmonary arterial thrombosis: literature review and clinical significance of a distinct entity. American Journal of Roentgenology. 2023; 221: 57–68.

[17] Boey E, Teo SG, Poh KK. Electrocardiographic findings in pulmonary embolism. Singapore Medical Journal. 2015; 56: 533–537.

[18] Co I, Eilbert W, Chiganos T. New electrocardiographic changes in patients diagnosed with pulmonary embolism. Journal of Emergency Medicine. 2017; 52: 280–285.

[19] Zheng XB, Wu HY, Zhang M, Yao BQ. Clinical significance of R-wave amplitude in lead V1 and inferobasal myocardial infarction in patients with inferior wall myocardial infarction. Annals of Noninvasive Electrocardiology. 2024; 29: e13114.

[20] Zuin M, Rigatelli G, Bilato C, Bongarzoni A, Casazza F, Zonzin P, et al. Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry. Thrombosis Research. 2022; 217: 15–21.

[21] Weekes AJ, Raper JD, Thomas AM, Lupez K, Cox CA, Esener D, et al. Electrocardiographic findings associated with early clinical deterioration in acute pulmonary embolism. Academic Emergency Medicine. 2022; 29: 1185–1196.

[22] Nilsson LT, Andersson T, Carlberg B, Johansson LÅ, Söderberg S. Electrocardiographic abnormalities and NT-proBNP levels at long-term follow-up of patients with dyspnea after pulmonary embolism. Scandinavian Cardiovascular Journal. 2024; 58: 2373090.

[23] Kaczyńska A, Bochowicz A, Kostrubiec M, Szulc M, Pruszczyk P. Electrocardiography and prediction of myocardial damage in patients with acute pulmonary embolism. Polish Archives of Internal Medicine. 2004; 112: 1039–1046. (In Polish)

[24] Janata K, Höchtl T, Wenzel C, Jarai R, Fellner B, Geppert A, et al. The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism. Clinical Research in Cardiology. 2012; 101: 329–337.

[25] Savelloni G, Gatto MC, Cancelli F, Barbetti A, Cogliati Dezza F, Franchi C, et al. Prognostic value of 12-leads electrocardiogram at emergency department in hospitalized patients with coronavirus disease-19. Journal of Clinical Medicine. 2022; 11: 2537.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.3 (2024) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Top